Bioinformatics studies on sequence, structure and functional relationships of proteins involved in the complement system
暂无分享,去创建一个
[1] R A Sayle,et al. RASMOL: biomolecular graphics for all. , 1995, Trends in biochemical sciences.
[2] V. Nussenzweig,et al. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes , 1982, The Journal of experimental medicine.
[3] R. Wade,et al. Classification of protein sequences by homology modeling and quantitative analysis of electrostatic similarity , 1999, Proteins.
[4] D. Lublin,et al. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. , 1996, Journal of immunology.
[5] B. F. Hall,et al. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. , 1989, Journal of immunology.
[6] H. E. Gilbert,et al. The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. , 2006, Journal of molecular biology.
[7] N. Guex,et al. SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.
[8] J. D.. The Human Factor , 2022 .
[9] G. Ambrus,et al. A True Autoactivating Enzyme , 2005, Journal of Biological Chemistry.
[10] T L Blundell,et al. An evaluation of the performance of an automated procedure for comparative modelling of protein tertiary structure. , 1993, Protein engineering.
[11] Marie-Noëlle Metz-Lutz,et al. SRPX2 mutations in disorders of language cortex and cognition. , 2006, Human molecular genetics.
[12] Ian A Wilson,et al. Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[13] H. Ariga,et al. Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46 (*) , 1995, The Journal of Biological Chemistry.
[14] J. Lambris,et al. A 34-amino acid peptide of the third component of complement mediates properdin binding. , 1988, Journal of immunology.
[15] A. Blom,et al. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b. , 2003, Molecular immunology.
[16] L. Presta,et al. Identification of an E-selectin region critical for carbohydrate recognition and cell adhesion [published erratum appears in J Cell Biol 1993 Feb;120(4):1071] , 1992, The Journal of cell biology.
[17] John D Lambris,et al. Solvent Accessibility of Native and Hydrolyzed Human Complement Protein 3 Analyzed by Hydrogen/Deuterium Exchange and Mass Spectrometry 1 , 2005, The Journal of Immunology.
[18] G. Lindahl,et al. Ig-binding surface proteins of Streptococcus pyogenes also bind human C4b-binding protein (C4BP), a regulatory component of the complement system. , 1995, Journal of immunology.
[19] P. Barlow,et al. Dissecting Sites Important for Complement Regulatory Activity in Membrane Cofactor Protein (MCP; CD46)* , 2000, The Journal of Biological Chemistry.
[20] Gerald J. Wyckoff,et al. Rapid evolution of male reproductive genes in the descent of man , 2000, Nature.
[21] Chuong-Thu Thai,et al. Complement Components C5 and C7: Recombinant Factor I Modules of C7 Bind to the C345C Domain of C51 , 2004, The Journal of Immunology.
[22] Lin Wei,et al. Impact of the SpeB Protease on Binding of the Complement Regulatory Proteins Factor H and Factor H-Like Protein 1 by Streptococcus pyogenes , 2005, Infection and Immunity.
[23] Steven E. Brenner,et al. WebLogo: A sequence logo generator - eScholarship , 2004 .
[24] U. Schaible,et al. Borrelia Burgdorferi Infection in Mice: Aspects of Inflammation and Immune Responses , 1994 .
[25] Crystallization of human complement component C5. , 1998, Acta crystallographica. Section D, Biological crystallography.
[26] W R Taylor,et al. Homology modelling by distance geometry. , 1996, Folding & design.
[27] N. Grishin,et al. Structural classification of small, disulfide-rich protein domains. , 2006, Journal of molecular biology.
[28] D. Pérez-Caballero,et al. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. , 2002, American journal of human genetics.
[29] D. Gerlier,et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus , 1993, Journal of virology.
[30] W. Baldwin,et al. Functional characterization of soluble and membrane-bound forms of vaccinia virus complement control protein (VCP). , 1999, Molecular immunology.
[31] P. Zipfel,et al. Mapping of the adrenomedullin-binding domains in human complement factor H. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.
[32] G. Remuzzi,et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. , 2003, Human molecular genetics.
[33] B. Dahlbäck,et al. High affinity binding of human vitamin K-dependent protein S to a truncated recombinant beta-chain of C4b-binding protein expressed in Escherichia coli. , 1993, The Journal of biological chemistry.
[34] P. Zipfel,et al. Further Characterization of Complement Regulator-Acquiring Surface Proteins of Borrelia burgdorferi , 2001, Infection and Immunity.
[35] J. Winkelstein,et al. Soluble human complement receptor type 1 inhibits complement-mediated host defense. , 1994, Clinical and diagnostic laboratory immunology.
[36] R. Battistutta,et al. Structure at 1.44 A resolution of an N-terminally truncated form of the rat serum complement C3d fragment. , 2000, Biochimica et biophysica acta.
[37] R. Ogata,et al. Active sites in complement component C3 mapped by mutations at indels. , 1998, Journal of immunology.
[38] P. Zipfel,et al. FHR-1, an additional human plasma protein, binds to complement regulator-acquiring surface proteins of Borrelia burgdorferi , 2008 .
[39] R. Campbell,et al. Structural basis of the polymorphism of human complement components C4A and C4B: gene size, reactivity and antigenicity. , 1986, The EMBO journal.
[40] J. Jensenius,et al. Complement Receptor 1/Cd35 Is a Receptor for Mannan-Binding Lectin , 2000, The Journal of experimental medicine.
[41] P. Bork,et al. Protein domain analysis in the era of complete genomes , 2002, FEBS letters.
[42] D. Fearon,et al. Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins , 1987, The Journal of experimental medicine.
[43] W. Wooster,et al. Crystal structure of , 2005 .
[44] A Godzik,et al. Surface map comparison: studying function diversity of homologous proteins. , 2001, Journal of molecular biology.
[45] W. Gray,et al. Third component of human complement: localization of the internal thiolester bond. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[46] R. Discipio,et al. Function of the factor I modules (FIMS) of human complement component C6. , 1998, The Journal of biological chemistry.
[47] B. Morgan,et al. Pigs Express Multiple Forms of Decay-Accelerating Factor (CD55), All of Which Contain Only Three Short Consensus Repeats1 , 2000, The Journal of Immunology.
[48] Yuzuru Suzuki,et al. Regulator of complement activation (RCA) gene cluster in Xenopus tropicalis , 2009, Immunogenetics.
[49] V. Holers,et al. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation. , 2007, Molecular immunology.
[50] P Rotkiewicz,et al. Generalized comparative modeling (GENECOMP): A combination of sequence comparison, threading, and lattice modeling for protein structure prediction and refinement , 2001, Proteins.
[51] M. Grainger,et al. A novel Sushi domain-containing protein of Plasmodium falciparum. , 2005, Molecular and biochemical parasitology.
[52] Hans Neurath,et al. The Kinemage: A tool for scientific communication , 1996 .
[53] T. Stehle,et al. The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[54] A. Blom,et al. Localization of a Hydrophobic Binding Site for Anticoagulant Protein S on the β-Chain of Complement Regulator C4b-binding Protein* , 2001, The Journal of Biological Chemistry.
[55] R. Jacobson,et al. Measles virus receptors: SLAM and CD46 , 2004, Reviews in medical virology.
[56] H. Müller-Eberhard,et al. The membrane attack complex of complement. , 1986, Annual review of immunology.
[57] G. Hageman,et al. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.
[58] J. Lambris,et al. Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Open Reading Frame 4 Protein (Kaposica) Is a Functional Homolog of Complement Control Proteins , 2003, Journal of Virology.
[59] Elisa Leung,et al. The complement regulator C4b-binding protein (C4BP) interacts with both the C4c and C4dg subfragments of the parent C4b ligand: evidence for synergy in C4BP subsite binding. , 2006, Biochemistry.
[60] Timothy S Baker,et al. Structure of decay-accelerating factor bound to echovirus 7: A virus-receptor complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Oppermann,et al. The contrasting mechanisms of serum resistance of Neisseria gonorrhoeae and group B Neisseria meningitidis. , 1999, Molecular immunology.
[62] G. Remuzzi,et al. The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20. , 2001, Journal of the American Society of Nephrology : JASN.
[63] E. Verrier,et al. Pexelizumab – a C5 complement inhibitor for use in both acute myocardial infarction and cardiac surgery with cardiopulmonary bypass , 2005, Expert opinion on biological therapy.
[64] G. Ball,et al. Human C4b-binding Protein, Structural Basis for Interaction with Streptococcal M Protein, a Major Bacterial Virulence Factor* , 2006, Journal of Biological Chemistry.
[65] R. Huber,et al. Crystal structure analysis and molecular model of human C3a anaphylatoxin. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[66] W. Fridman,et al. Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome , 2004, Journal of Medical Genetics.
[67] R. Marconi,et al. Demonstration of Factor H-Like Protein 1 Binding to Treponema denticola, a Pathogen Associated with Periodontal Disease in Humans , 2005, Infection and Immunity.
[68] R C Wade,et al. MolSurfer: two-dimensional maps for navigating three-dimensional structures of proteins. , 1999, Trends in biochemical sciences.
[69] C. Mold,et al. Localization of classical and alternative pathway regulatory activity within the decay-accelerating factor. , 1996, Journal of immunology.
[70] W. Burgdorfer,et al. Relapsing fever spirochetes: an aberrant strain of Borrelia parkeri from Oregon. , 1955, Experimental parasitology.
[71] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[72] J. Atkinson,et al. Synergy between Two Active Sites of Human Complement Receptor Type 1 (CD35) in Complement Regulation: Implications for the Structure of the Classical Pathway C3 Convertase and Generation of More Potent Inhibitors1 , 2005, The Journal of Immunology.
[73] J. Krushkal,et al. Evolutionary history of orthopoxvirus proteins similar to human complement regulators , 2005, Gene.
[74] R Sánchez,et al. Advances in comparative protein-structure modelling. , 1997, Current opinion in structural biology.
[75] H. Okada,et al. Alternative exon usage in the 3′ region of a single gene generates glycosylphosphatidylinositol-anchored and transmembrane forms of rat decay-accelerating factor , 2000, Immunogenetics.
[76] A. Blom,et al. Bordetella pertussis binds to human C4b‐binding protein (C4BP) at a site similar to that used by the natural ligand C4b , 2001, European journal of immunology.
[77] Haino,et al. Structural characterization of mouse CD97 and study of its specific interaction with the murine decay‐accelerating factor (DAF, CD55) , 1999, Immunology.
[78] B. Fleckenstein,et al. New member of the multigene family of complement control proteins in herpesvirus saimiri , 1992, Journal of virology.
[79] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[80] P. Kraulis. A program to produce both detailed and schematic plots of protein structures , 1991 .
[81] E. Levashina,et al. Thioester-containing proteins and insect immunity. , 2004, Molecular immunology.
[82] Sean R. Eddy,et al. Biological Sequence Analysis: Probabilistic Models of Proteins and Nucleic Acids , 1998 .
[83] Christopher D. Richardson,et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain) , 1993, Cell.
[84] J. Atkinson,et al. Evolution of the complement system. , 1991, Immunology today.
[85] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[86] W Reichardt,et al. Streptococcus pyogenes. , 2001, Contributions to microbiology.
[87] A. Lesk,et al. The relation between the divergence of sequence and structure in proteins. , 1986, The EMBO journal.
[88] I. Gigli,et al. Evolutionary relationships among proteins encoded by the regulator of complement activation gene cluster. , 2000, Molecular biology and evolution.
[89] K. Christopher Garcia,et al. The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.
[90] W. Grabarse,et al. Monomeric structures of the zymogen and active catalytic domain of complement protease c1r: further insights into the c1 activation mechanism. , 2002, Structure.
[91] B. Dahlbäck,et al. Serum Amyloid P Component Binding to C4b-binding Protein (*) , 1995, The Journal of Biological Chemistry.
[92] U. Ryan,et al. Soluble Human Complement Receptor 1 Limits Ischemic Damage in Cardiac Surgery Patients at High Risk Requiring Cardiopulmonary Bypass , 2004, Circulation.
[93] C. Sander,et al. Quality control of protein models : directional atomic contact analysis , 1993 .
[94] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[95] J. Grötzinger,et al. The Structure of the Interleukin-15α Receptor and Its Implications for Ligand Binding* , 2006, Journal of Biological Chemistry.
[96] D. Soares,et al. Complement Control Protein Modules in the Regulators of Complement Activation , 2005 .
[97] R. Pierson,et al. Hyperacute Lung Rejection in the Pig-to-Human Model 4: Evidence for Complement and Antibody Independent Mechanisms , 2005, Transplantation.
[98] S. Čučnik,et al. Avidity of anti-beta-2-glycoprotein I antibodies. , 2005, Autoimmunity reviews.
[99] The human C4b-binding protein beta-chain gene. , 1993, The Journal of biological chemistry.
[100] R. Ogata,et al. Distal Recognition Site for Classical Pathway Convertase Located in the C345C/Netrin Module of Complement Component C51 , 2000, The Journal of Immunology.
[101] S. Carroll,et al. Genome-scale approaches to resolving incongruence in molecular phylogenies , 2003, Nature.
[102] András Fiser,et al. Molecular Biophysics , 2022 .
[103] Piet Gros,et al. Structures of complement component C3 provide insights into the function and evolution of immunity , 2005, Nature.
[104] D. Pérez-Caballero,et al. Interaction between Complement Regulators and Streptococcus pyogenes: Binding of C4b-Binding Protein and Factor H/Factor H-Like Protein 1 to M18 Strains Involves Two Different Cell Surface Molecules1 , 2004, The Journal of Immunology.
[105] B. Palanca,et al. A critical role for murine complement regulator crry in fetomaternal tolerance. , 2000, Science.
[106] M. Kirkitadze,et al. Structure and flexibility of the multiple domain proteins that regulate complement activation , 2001, Immunological reviews.
[107] V. Holers,et al. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. , 1994, Journal of immunology.
[108] M. Telen,et al. Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. , 1991, Journal of immunology.
[109] B. Nagar,et al. X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. , 1998, Science.
[110] B. Stevenson,et al. Differential Binding of Host Complement Inhibitor Factor H by Borrelia burgdorferi Erp Surface Proteins: a Possible Mechanism Underlying the Expansive Host Range of Lyme Disease Spirochetes , 2002, Infection and Immunity.
[111] J. Atkinson,et al. Membrane cofactor protein (MCP or CD46) is a cellular pilus receptor for pathogenic Neisseria , 1997, Molecular microbiology.
[112] S. Antonarakis,et al. Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[113] Maria Jesus Martin,et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..
[114] L. Klickstein,et al. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. , 1997, Immunity.
[115] K. Chou,et al. Prediction of the Tertiary Structure of the Complement Control Protein Module , 1997, Journal of protein chemistry.
[116] A. Gaggar,et al. CD46 is a cellular receptor for group B adenoviruses , 2003, Nature Medicine.
[117] D. Hourcade,et al. Sites within the complement C3b/C4b receptor important for the specificity of ligand binding. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[118] R. Smith,et al. Targeting anticomplement agents. , 2002, Biochemical Society transactions.
[119] R. Bollinger,et al. The effect of soluble complement receptor type 1 on hyperacute allograft rejection. , 1991, The Journal of surgical research.
[120] Robert B Sim,et al. Purification and structural studies on the complement-system control protein beta 1H (Factor H). , 1982, The Biochemical journal.
[121] M. Kaplan. Eculizumab (Alexion). , 2002, Current opinion in investigational drugs.
[122] A. Sali,et al. Protein Structure Prediction and Structural Genomics , 2001, Science.
[123] M. Pangburn,et al. Disease-associated sequence variations in factor H: a structural biology approach. , 2006, Advances in experimental medicine and biology.
[124] M. Shoham,et al. Molecular modeling and mechanism of action of human decay-accelerating factor. , 1996, Protein engineering.
[125] J. Atkinson,et al. Structure of the gene for human complement protein decay accelerating factor. , 1990, Journal of immunology.
[126] T. Horan,et al. CSMD1 Is a Novel Multiple Domain Complement-Regulatory Protein Highly Expressed in the Central Nervous System and Epithelial Tissues1 , 2006, The Journal of Immunology.
[128] Roland L. Dunbrack,et al. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.
[129] A. Day,et al. Structure-function relationships of the complement components. , 1989, Immunology today.
[130] J. Atkinson,et al. Human complement receptor type 1 (CR1) binds to a major malarial adhesin. , 2002, Trends in molecular medicine.
[131] L. McDaniel,et al. In vivo binding of complement regulator factor H by Streptococcus pneumoniae. , 2005, The Journal of infectious diseases.
[132] E. Johnsson,et al. Human complement regulators: a major target for pathogenic microorganisms. , 2000, Current opinion in immunology.
[133] D. Lipman,et al. Improved tools for biological sequence comparison. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[134] M. Billeter,et al. Comparison of protein structures determined by NMR in solution and by X-ray diffraction in single crystals , 1992, Quarterly Reviews of Biophysics.
[135] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[136] K. Toyoshima,et al. A Novel Chicken Membrane-Associated Complement Regulatory Protein: Molecular Cloning and Functional Characterization1 , 2001, The Journal of Immunology.
[137] S. Čučnik,et al. High avidity anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome , 2004, Annals of the rheumatic diseases.
[138] Opportunities for New Therapies Based on the Natural Regulators of Complement Activation , 2005, Annals of the New York Academy of Sciences.
[139] R. Peek,et al. The Role of Decay-accelerating Factor as a Receptor for Helicobacter pylori and a Mediator of Gastric Inflammation*♦ , 2006, Journal of Biological Chemistry.
[140] S. Rodríguez de Córdoba,et al. The human complement factor H: functional roles, genetic variations and disease associations. , 2004, Molecular immunology.
[141] T. Meri,et al. Complement Evasion by Borrelia burgdorferi: Serum-Resistant Strains Promote C3b Inactivation , 2001, Infection and Immunity.
[142] H. Lior,et al. Haemolytic-uraemic syndrome , 1994, The Lancet.
[143] C. Sander,et al. Errors in protein structures , 1996, Nature.
[144] K. Garcia,et al. Structure of the Quaternary Complex of Interleukin-2 with Its α, ß, and γc Receptors , 2005, Science.
[145] Pnur BnlqN Moonn,et al. Solution of the Structure , 2007 .
[146] M. Marques,et al. Hemolytic uremic syndrome revisited: Shiga toxin, factor H, and fibrin generation. , 2004, American journal of clinical pathology.
[147] Christine Gaboriaud,et al. The Crystal Structure of the Globular Head of Complement Protein C1q Provides a Basis for Its Versatile Recognition Properties* , 2003, Journal of Biological Chemistry.
[148] R. Campbell,et al. Internal homologies of the Ba fragment from human complement component Factor B, a class III MHC antigen. , 1984, The EMBO journal.
[149] Ruth Nussinov,et al. A method for simultaneous alignment of multiple protein structures , 2004, Proteins.
[150] G. Remuzzi,et al. Complement factor H mutation in familial thrombotic thrombocytopenic purpura with ADAMTS13 deficiency and renal involvement. , 2005, Journal of the American Society of Nephrology : JASN.
[151] John D Lambris,et al. Complement diversity: a mechanism for generating immune diversity? , 1998, Immunology today.
[152] I. Campbell,et al. Solution structure of a pair of complement modules by nuclear magnetic resonance. , 1993, Journal of molecular biology.
[153] C. A. Thomas,et al. Molecular cloning. , 1977, Advances in pathobiology.
[154] P. Lusso,et al. Human Herpesvirus 6 and Measles Virus Employ Distinct CD46 Domains for Receptor Function* , 2002, The Journal of Biological Chemistry.
[155] D. Marion,et al. Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family. , 1998, Biochemistry.
[156] A. Blom,et al. A Cluster of Positively Charged Amino Acids in the C4BP α-Chain Is Crucial for C4b Binding and Factor I Cofactor Function* , 1999, The Journal of Biological Chemistry.
[157] F. Cohen,et al. An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.
[158] P. Zipfel,et al. Recruitment of Complement Factor H-Like Protein 1 Promotes Intracellular Invasion by Group A Streptococci , 2003, Infection and Immunity.
[159] D. Uhrín,et al. Functional Insights from the Structure of the Multifunctional C345C Domain of C5 of Complement* , 2005, Journal of Biological Chemistry.
[160] T. L. Blundell,et al. Knowledge-based prediction of protein structures and the design of novel molecules , 1987, Nature.
[161] G. Cornelis,et al. Role of the YadA protein in prevention of opsonization of Yersinia enterocolitica by C3b molecules , 1993, Infection and immunity.
[162] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[163] R. Doolittle,et al. Progressive sequence alignment as a prerequisitetto correct phylogenetic trees , 2007, Journal of Molecular Evolution.
[164] D. Cue,et al. Acquisition of Regulators of Complement Activation by Streptococcus pyogenes Serotype M1 , 2002, Infection and Immunity.
[165] D. Isenman,et al. Identification of Residues within the 727–767 Segment of Human Complement Component C3 Important for Its Interaction with Factor H and with Complement Receptor 1 (CR1, CD35)* , 1999, The Journal of Biological Chemistry.
[166] A. Buil,et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. , 2005, Human molecular genetics.
[167] Brian O. Smith,et al. Structural Analysis of the Complement Control Protein (CCP) Modules of GABAB Receptor 1a , 2004, Journal of Biological Chemistry.
[168] R. Liddington,et al. Crystal structure of the A domain from complement factor B reveals an integrin-like open conformation. , 2004, Structure.
[169] C. Smith,et al. The activation of human complement component C5 by a fluid phase C5 convertase. , 1983, The Journal of biological chemistry.
[170] Wei Ling Lau,et al. Identification of two new members of the CSMD gene family. , 2003, Genomics.
[171] P. Lachmann,et al. Novel cleavage products of the third component of human complement. , 1980, Molecular immunology.
[172] H. Okada,et al. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing. , 1995, Journal of immunology.
[173] R. Frade,et al. Evidence for a new transcript of the Epstein-Barr virus/C3d receptor (CR2, CD21) which is due to alternative exon usage. , 1998, Molecular immunology.
[174] N. C. Price,et al. Co‐operativity between modules within a C3b‐binding site of complement receptor type 1 , 1999, FEBS letters.
[175] J. Atkinson,et al. Mutations in CD46, a complement regulatory protein, predispose to atypical HUS. , 2004, Trends in molecular medicine.
[176] S. Rodríguez de Córdoba,et al. Physical linkage of the human genes coding for complement factor H and coagulation factor XIII B subunit. , 1990, Genomics.
[177] Adrian A Canutescu,et al. Access the most recent version at doi: 10.1110/ps.03154503 References , 2003 .
[178] E. Myers,et al. Basic local alignment search tool. , 1990, Journal of molecular biology.
[179] C. Smith,et al. Visualization of human C4b-binding protein and its complexes with vitamin K-dependent protein S and complement protein C4b. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[180] B. Moss,et al. Inhibition of the complement cascade by the major secretory protein of vaccinia virus. , 1990, Science.
[181] A. Oldstone. Molecular Mimicry , 1989, Current Topics in Microbiology and Immunology.
[182] J. Atkinson,et al. Membrane cofactor protein (CD46) of complement. Processing differences related to alternatively spliced cytoplasmic domains. , 1994, The Journal of biological chemistry.
[183] E. Zuiderweg,et al. Tertiary structure of human complement component C5a in solution from nuclear magnetic resonance data. , 1989, Biochemistry.
[184] A. Mizota,et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. , 2006, Molecular vision.
[185] P. Hass,et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.
[186] E. Souied,et al. Y402H complement factor H polymorphism associated with exudative age-related macular degeneration in the French population. , 2005, Molecular vision.
[187] J. Atkinson,et al. Structure–function relationships of complement receptor type 1 , 2001, Immunological reviews.
[188] Werner Braun,et al. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules , 1998, J. Comput. Chem..
[189] A. Blom,et al. Functional Activity of the Complement Regulator Encoded by Kaposi's Sarcoma-associated Herpesvirus* , 2003, The Journal of Biological Chemistry.
[190] D. Hourcade,et al. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein , 1995, The Journal of experimental medicine.
[191] E. Hawrot,et al. The metabotropic GABA receptor: molecular insights and their functional consequences , 2000, Cellular and Molecular Life Sciences CMLS.
[192] G. Nemerow,et al. Molecular cloning of the cDNA encoding the Epstein-Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[193] I. Campbell,et al. Fibronectin structure and assembly. , 1994, Current opinion in cell biology.
[194] Dirk Walther,et al. MolSurfer: a macromolecular interface navigator , 2003, Nucleic Acids Res..
[195] K. Bromek,et al. Structure of the C3b Binding Site of CR1 (CD35), the Immune Adherence Receptor , 2002, Cell.
[196] T. Meri,et al. Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis , 2005, European journal of immunology.
[197] S. Christensen,et al. The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. , 1990, Journal of immunology.
[198] P Bork,et al. Structure and distribution of modules in extracellular proteins , 1996, Quarterly Reviews of Biophysics.
[199] A. Egorov,et al. A study of the structure of human M-globulin subunits by maleation. , 1971, Immunochemistry.
[200] Thomas Walz,et al. Structural transitions of complement component C3 and its activation products , 2006, Proceedings of the National Academy of Sciences.
[201] Ching-Yu Cheng,et al. Association of the Y402H polymorphism in complement factor H gene and neovascular age-related macular degeneration in Chinese patients. , 2006, Investigative ophthalmology & visual science.
[202] J. Thornton,et al. Stereochemical quality of protein structure coordinates , 1992, Proteins.
[203] V. Michael Holers,et al. Structure of Complement Receptor 2 in Complex with Its C3d Ligand , 2001, Science.
[204] L. McDaniel,et al. Interaction of human factor H with PspC of Streptococcus pneumoniae. , 2004, The Indian journal of medical research.
[205] Anton Nekrutenko,et al. Signatures of domain shuffling in the human genome. , 2002, Genome research.
[206] Michael Schroeder,et al. SCOPPI: a structural classification of protein–protein interfaces , 2005, Nucleic Acids Res..
[207] T. Goodship. Inherited dysregulation of the complement system. , 2004, Bulletin et memoires de l'Academie royale de medecine de Belgique.
[208] R. Cramer,et al. Validation of the general purpose tripos 5.2 force field , 1989 .
[209] S. Minoshima,et al. A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1. , 2003, Biochemical and biophysical research communications.
[210] A. Sali,et al. Large-scale protein structure modeling of the Saccharomyces cerevisiae genome. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[211] Manuel C. Peitsch,et al. SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..
[212] C. M. Fletcher,et al. Structure of a soluble, glycosylated form of the human complement regulatory protein CD59. , 1994, Structure.
[213] T. Seya,et al. Regulator of Complement Activation (RCA) Locus in Chicken: Identification of Chicken RCA Gene Cluster and Functional RCA Proteins1 , 2005, The Journal of Immunology.
[214] Aidan Budd,et al. Bacterial α2-macroglobulins: colonization factors acquired by horizontal gene transfer from the metazoan genome? , 2004, Genome Biology.
[215] E. Davie,et al. Structure of transglutaminases. , 1990, The Journal of biological chemistry.
[216] W. Wong,et al. Structure of the gene for the F allele of complement receptor type 1 and sequence of the coding region unique to the S allele. , 1993, Journal of immunology.
[217] 滝沢 壽男. Complement inhibitor of rat cell membrane resembling mouse Crry/p65 , 1995 .
[218] O. Doumbo,et al. Expansion of the Knops blood group system and subdivision of Sla , 2002, Transfusion.
[219] J. Atkinson,et al. Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. , 1997, Virology.
[220] Peer Bork,et al. SMART 4.0: towards genomic data integration , 2004, Nucleic Acids Res..
[221] D. Hochstrasser,et al. The focusing positions of polypeptides in immobilized pH gradients can be predicted from their amino acid sequences , 1993, Electrophoresis.
[222] W. Baldwin,et al. Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. , 1997, Transplantation.
[223] B. Dahlbäck,et al. The amino-terminal module of the C4b-binding protein alpha-chain is crucial for C4b binding and factor I-cofactor function. , 1997, The Biochemical journal.
[224] M. Kirkitadze,et al. Independently melting modules and highly structured intermodular junctions within complement receptor type 1. , 1999, Biochemistry.
[225] Robert B Sim,et al. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. , 1997, Journal of immunology.
[226] C. Newbold,et al. Mapping of the Region of Complement Receptor (CR) 1 Required for Plasmodium falciparum Rosetting and Demonstration of the Importance of CR1 in Rosetting in Field Isolates1 , 2000, The Journal of Immunology.
[227] J. Marx. Genetics. A clearer view of macular degeneration. , 2006, Science.
[228] K. Murthy,et al. Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[229] D. Benayahu,et al. Molecular and cellular characterization of SEL‐OB/SVEP1 in osteogenic cells in vivo and in vitro , 2006, Journal of cellular physiology.
[230] S. Richards,et al. Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. , 2004, The New England journal of medicine.
[231] B. Bradt,et al. Murine C4b-binding protein. Mapping of the ligand binding site and the N-terminus of the pre-protein. , 1993, Journal of immunology.
[232] D. Pérez-Caballero,et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. , 2001, American journal of human genetics.
[233] Piet Gros,et al. Structure of C3b reveals conformational changes that underlie complement activity , 2006, Nature.
[234] R. Ogata,et al. Active sites in complement components C5 and C3 identified by proximity to indels in the C3/4/5 protein family. , 1999, Journal of immunology.
[235] J. Parkinson,et al. Large-scale modelling as a route to multiple surface comparisons of the CCP module family. , 2005, Protein engineering, design & selection : PEDS.
[236] I. Campbell,et al. NMR studies of a viral protein that mimics the regulators of complement activation. , 1997, Journal of molecular biology.
[237] T. Kawai,et al. Outer membrane protein 100, a versatile virulence factor of Actinobacillus actinomycetemcomitans , 2003, Molecular microbiology.
[238] J. Lambris,et al. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. , 1988, The Journal of biological chemistry.
[239] B. Morgan,et al. Complement therapeutics; history and current progress. , 2003, Molecular immunology.
[240] J. Collins,et al. Significance of protein sequence similarities. , 1990, Methods in enzymology.
[241] S. Ranganathan,et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein. , 2000, European Journal of Immunology.
[242] Peer Bork,et al. Recent improvements to the SMART domain-based sequence annotation resource , 2002, Nucleic Acids Res..
[243] C. Mold,et al. Structure/function studies of human decay‐accelerating factor , 2000, Immunology.
[244] P. Tommila,et al. Analysis of variants in the complement factor H, the elongation of very long chain fatty acids-like 4 and the hemicentin 1 genes of age-related macular degeneration in the Finnish population. , 2006, Molecular vision.
[245] J. Greer. Comparative modeling methods: Application to the family of the mammalian serine proteases , 1990, Proteins.
[246] Ruth Nussinov,et al. MultiProt - A Multiple Protein Structural Alignment Algorithm , 2002, WABI.
[247] J. Goodship,et al. Genetic studies into inherited and sporadic hemolytic uremic syndrome. , 1998, Kidney international.
[248] J. Nyborg,et al. The structure of bovine complement component 3 reveals the basis for thioester function. , 2006, Journal of molecular biology.
[249] Dimitrios Morikis,et al. Studies of Structure-Activity Relations of Complement Inhibitor Compstatin 1 , 2003 .
[250] V. Fischetti,et al. Identification of the Streptococcal M Protein Binding Site on Membrane Cofactor Protein (CD46)1 , 2002, The Journal of Immunology.
[251] P. Zipfel,et al. An interactive web database of factor H‐associated hemolytic uremic syndrome mutations: insights into the structural consequences of disease‐associated mutations , 2006, Human mutation.
[252] J. Goodship,et al. Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[253] Frcp C. Mark Taylor. Hemolytic-Uremic Syndrome and Complement Factor H Deficiency: Clinical Aspects , 2001, Seminars in thrombosis and hemostasis.
[254] B. Rost. Twilight zone of protein sequence alignments. , 1999, Protein engineering.
[255] J. Parma,et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. , 1998, The New England journal of medicine.
[256] M. Carroll,et al. The complement system in B cell regulation. , 2004, Molecular immunology.
[257] J. Goodship,et al. Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. , 2001, American journal of human genetics.
[258] M. L. Le Beau,et al. Molecular cloning and chromosomal localization of human membrane cofactor protein (MCP). Evidence for inclusion in the multigene family of complement-regulatory proteins , 1988, The Journal of experimental medicine.
[259] Katherine A. Oehlberg,et al. Variola virus immune evasion proteins. , 2003, Microbes and infection.
[260] B. Paul Morgan,et al. Molecular Dissection of Interactions between Components of the Alternative Pathway of Complement and Decay Accelerating Factor (CD55)* , 2005, Journal of Biological Chemistry.
[261] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[262] J. Atkinson,et al. Structure-Function Analysis of the Active Sites of Complement Receptor Type 1* , 1998, The Journal of Biological Chemistry.
[263] A. Blom,et al. Positively charged amino acids at the interface between alpha-chain CCP1 and CCP2 of C4BP are required for regulation of the classical C3-convertase. , 2000, Molecular immunology.
[264] Didier Raoult,et al. Molecular identification by , 2000 .
[265] J. Moulds. A review of the Knops blood group: separating fact from fallacy , 2002, Immunohematology.
[266] L. Jorde,et al. Duplication and divergence in humans and chimpanzees , 2006, BioEssays : news and reviews in molecular, cellular and developmental biology.
[267] M. Levitt. Accurate modeling of protein conformation by automatic segment matching. , 1992, Journal of molecular biology.
[268] D. Gerlier,et al. CD46 (membrane cofactor protein) associates with multiple β1 integrins and tetraspans , 2000, European journal of immunology.
[269] David T. Williams,et al. Structural and Functional Insights into the Interaction of Echoviruses and Decay-accelerating Factor* , 2006, Journal of Biological Chemistry.
[270] K. Murthy,et al. RETRACTED: Crystal Structure of a Complement Control Protein that Regulates Both Pathways of Complement Activation and Binds Heparan Sulfate Proteoglycans , 2001, Cell.
[271] Nathan A. Baker,et al. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations , 2004, Nucleic Acids Res..
[272] D. Hourcade,et al. Decay Accelerating Activity of Complement Receptor Type 1 (CD35) , 1999, The Journal of Biological Chemistry.
[273] J. Hamann,et al. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF) , 1997 .
[274] J. Atkinson,et al. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence , 2001, Cellular microbiology.
[275] M. Mizuno,et al. The possibilities and pitfalls for anti-complement therapies in inflammatory diseases. , 2004, Current drug targets. Inflammation and allergy.
[276] I. Campbell,et al. Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. , 1992, Biochemistry.
[277] R C Wade,et al. Species dependence of enzyme‐substrate encounter rates for triose phosphate isomerases , 1998, Proteins.
[278] D. Lublin,et al. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding , 1995, Journal of virology.
[279] P Lukacik,et al. Complement regulation at the molecular level: the structure of decay-accelerating factor. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[280] J. Fontecilla-Camps,et al. THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R , 2002 .
[281] E. Johnsson,et al. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. , 1998, Journal of immunology.
[282] G. D. Ross,et al. Membrane complement receptors specific for bound fragments of C3. , 1985, Advances in immunology.
[283] Zhiping Nie,et al. Variola virus immune evasion design: Expression of a highly efficient inhibitor of human complement , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[284] Arne Elofsson,et al. All are not equal: A benchmark of different homology modeling programs , 2005, Protein science : a publication of the Protein Society.
[285] P. Berggren,et al. Cell Signaling by the Type IV Pili of Pathogenic Neisseria* , 1998, The Journal of Biological Chemistry.
[286] Edwin M Stone,et al. Macular degeneration. , 2007, Annual review of medicine.
[287] D. Fearon,et al. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis , 1988, The Journal of experimental medicine.
[288] A. Sahu,et al. Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein , 2005, Journal of Virology.
[289] M. Pangburn,et al. Native conformations of human complement components C3 and C4 show different dependencies on thioester formation. , 1998, The Biochemical journal.
[290] K. Murthy,et al. Mapping of regions within the vaccinia virus complement control protein involved in dose-dependent binding to key complement components and heparin using surface plasmon resonance. , 2003, Biochimica et biophysica acta.
[291] D. Higgins,et al. T-Coffee: A novel method for fast and accurate multiple sequence alignment. , 2000, Journal of molecular biology.
[292] Liam J. McGuffin,et al. The PSIPRED protein structure prediction server , 2000, Bioinform..
[293] S. Meri,et al. The factor H protein family. , 1999, Immunopharmacology.
[294] S. Narayana,et al. Crystal Structure of a Complement Factor D Mutant Expressing Enhanced Catalytic Activity (*) , 1995, The Journal of Biological Chemistry.
[295] T. Woodruff,et al. Increased Potency of a Novel Complement Factor 5a Receptor Antagonist in a Rat Model of Inflammatory Bowel Disease , 2005, Journal of Pharmacology and Experimental Therapeutics.
[296] J. Bergelson,et al. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55) , 1995, Journal of virology.
[297] D. Birmingham,et al. CR1 and CR1‐like: the primate immune adherence receptors , 2001, Immunological reviews.
[298] L. Giudice,et al. Cell surface adhesion of pregnancy-associated plasma protein-A is mediated by four clusters of basic residues located in its third and fourth CCP module. , 2004, European journal of biochemistry.
[299] G. Ambrus,et al. The structure of MBL-associated serine protease-2 reveals that identical substrate specificities of C1s and MASP-2 are realized through different sets of enzyme-substrate interactions. , 2004, Journal of molecular biology.
[300] S. Wodak,et al. Modelling the polypeptide backbone with 'spare parts' from known protein structures. , 1989, Protein engineering.
[301] Philipp E. Scherer,et al. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.
[302] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[303] Jürgen Brickmann,et al. A new approach to analysis and display of local lipophilicity/hydrophilicity mapped on molecular surfaces , 1993, J. Comput. Aided Mol. Des..
[304] H. Willison,et al. Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome , 2005, Annals of neurology.
[305] Peer Bork,et al. SMART, a simple modular architecture research tool , 1998 .
[306] L. Kelley,et al. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.
[307] P. Zipfel,et al. Identification of the second heparin-binding domain in human complement factor H. , 1998, Journal of immunology.
[308] Pietro Roversi,et al. An atomic resolution model for assembly, architecture, and function of the Dr adhesins. , 2004, Molecular cell.
[309] A. Blom,et al. Binding of C4b-binding protein to porin: a molecular mechanism of serum resistance of Neisseria gonorrhoeae , 2001 .
[310] K. Bromek,et al. Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces , 2004, Protein science : a publication of the Protein Society.
[311] J. Parkinson,et al. Central modules of the vaccinia virus complement control protein are not in extensive contact. , 1999, The Biochemical journal.
[312] M J Sternberg,et al. Misleading local sequence alignments: implications for comparative protein modelling. , 1998, Protein engineering.
[313] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[314] T L Blundell,et al. Knowledge based modelling of homologous proteins, Part II: Rules for the conformations of substituted sidechains. , 1987, Protein engineering.
[315] G. Remuzzi,et al. Combined kidney and liver transplantation for familial haemolytic uraemic syndrome , 2002, The Lancet.
[316] B. Bettler,et al. Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. , 1997, Nature.
[317] B. Dahlbäck,et al. The Amino-terminal Module of the C4b-binding Protein β-Chain Contains the Protein S-binding Site* , 1996, The Journal of Biological Chemistry.
[318] R. Ravelli,et al. Adhesion mechanism of human β2‐glycoprotein I to phospholipids based on its crystal structure , 1999, The EMBO journal.
[319] O. Spiller,et al. Mapping CD55 Function , 2003, The Journal of Biological Chemistry.
[320] M. Dierich,et al. Role of complement in HIV infection. , 1997, Annual review of immunology.
[321] E. A. Uvarova,et al. Species-specific differences in the structure of orthopoxvirus complement-binding protein , 2001, Virus research.
[322] D. Higgins,et al. Multiple sequence alignments. , 2005, Current opinion in structural biology.
[323] N. Ling,et al. Localization of the heparin binding site of follistatin , 1992, Molecular and Cellular Endocrinology.
[324] S. Shchelkunov,et al. Conserved Surface-Exposed K/R-X-K/R Motifs and Net Positive Charge on Poxvirus Complement Control Proteins Serve as Putative Heparin Binding Sites and Contribute to Inhibition of Molecular Interactions with Human Endothelial Cells: a Novel Mechanism for Evasion of Host Defense , 2000, Journal of Virology.
[325] P. A. Biro,et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[326] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[327] R. Wetsel,et al. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity. , 1982, Journal of immunology.
[328] J. Atkinson,et al. Membrane cofactor protein. , 1992, Current topics in microbiology and immunology.
[329] Kenneth M. Yamada,et al. STRUCTURE AND FUNCTION OF FIBRONECTIN , 1982 .
[330] P E Bourne,et al. Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. , 1998, Protein engineering.